131 related articles for article (PubMed ID: 16824176)
1. Trends in controlled-release oxycodone (OxyContin) prescribing among Medicaid recipients in Kentucky, 1998-2002.
Havens JR; Talbert JC; Walker R; Leedham C; Leukefeld CG
J Rural Health; 2006; 22(3):276-8. PubMed ID: 16824176
[TBL] [Abstract][Full Text] [Related]
2. Medical cost savings associated with an extended-release opioid with abuse-deterrent technology in the US.
Rossiter LF; Kirson NY; Shei A; White AG; Birnbaum HG; Ben-Joseph R; Michna E
J Med Econ; 2014 Apr; 17(4):279-87. PubMed ID: 24559196
[TBL] [Abstract][Full Text] [Related]
3. Trends and geographic variation of opiate medication use in state Medicaid fee-for-service programs, 1996 to 2002.
Zerzan JT; Morden NE; Soumerai S; Ross-Degnan D; Roughead E; Zhang F; Simoni-Wastila L; Sullivan SD
Med Care; 2006 Nov; 44(11):1005-10. PubMed ID: 17063132
[TBL] [Abstract][Full Text] [Related]
4. Rates of opioid dispensing and overdose after introduction of abuse-deterrent extended-release oxycodone and withdrawal of propoxyphene.
Larochelle MR; Zhang F; Ross-Degnan D; Wharam JF
JAMA Intern Med; 2015 Jun; 175(6):978-87. PubMed ID: 25895077
[TBL] [Abstract][Full Text] [Related]
5. Impact of abuse-deterrent OxyContin on prescription opioid utilization.
Hwang CS; Chang HY; Alexander GC
Pharmacoepidemiol Drug Saf; 2015 Feb; 24(2):197-204. PubMed ID: 25393216
[TBL] [Abstract][Full Text] [Related]
6. A profile of OxyContin addiction.
Hays LR
J Addict Dis; 2004; 23(4):1-9. PubMed ID: 15339710
[TBL] [Abstract][Full Text] [Related]
7. Seeking drug treatment for OxyContin abuse: a chart review of consecutive admissions to a substance abuse treatment facility in Kentucky.
Hays L; Kirsh KL; Passik SD
J Natl Compr Canc Netw; 2003 Jul; 1(3):423-8. PubMed ID: 19761073
[TBL] [Abstract][Full Text] [Related]
8. Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004.
Cicero TJ; Inciardi JA; Muñoz A
J Pain; 2005 Oct; 6(10):662-72. PubMed ID: 16202959
[TBL] [Abstract][Full Text] [Related]
9. Attractiveness of reformulated OxyContin(R) tablets: assessing comparative preferences and tampering potential.
Sellers EM; Perrino PJ; Colucci SV; Harris SC
J Psychopharmacol; 2013 Sep; 27(9):808-16. PubMed ID: 23784739
[TBL] [Abstract][Full Text] [Related]
10. The impact of a reformulation of extended-release oxycodone designed to deter abuse in a sample of prescription opioid abusers.
Havens JR; Leukefeld CG; DeVeaugh-Geiss AM; Coplan P; Chilcoat HD
Drug Alcohol Depend; 2014 Jun; 139():9-17. PubMed ID: 24721614
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of illicit drug use among individuals with chronic pain in the Commonwealth of Kentucky: an evaluation of patterns and trends.
Manchikanti L; Fellows B; Damron KS; Pampati V; McManus CD
J Ky Med Assoc; 2005 Feb; 103(2):55-62. PubMed ID: 15751456
[TBL] [Abstract][Full Text] [Related]
12. Medicaid prior authorization and controlled-release oxycodone.
Morden NE; Zerzan JT; Rue TC; Heagerty PJ; Roughead EE; Soumerai SB; Ross-Degnan D; Sullivan SD
Med Care; 2008 Jun; 46(6):573-80. PubMed ID: 18520311
[TBL] [Abstract][Full Text] [Related]
13. High dose controlled-release oxycodone in hospice care.
Bercovitch M; Adunsky A
J Pain Palliat Care Pharmacother; 2006; 20(4):33-9. PubMed ID: 17182504
[TBL] [Abstract][Full Text] [Related]
14. A comparison of rural and urban nonmedical prescription opioid users' lifetime and recent drug use.
Young AM; Havens JR; Leukefeld CG
Am J Drug Alcohol Abuse; 2012 May; 38(3):220-7. PubMed ID: 22211586
[TBL] [Abstract][Full Text] [Related]
15. Utilization and costs of medical services and prescription medications for rheumatoid arthritis among recipients covered by a state Medicaid program: a retrospective, cross-sectional, descriptive, database analysis.
Khanna R; Smith MJ
Clin Ther; 2007 Nov; 29(11):2456-67. PubMed ID: 18158087
[TBL] [Abstract][Full Text] [Related]
16. Transition from first illicit drug use to first injection drug use among rural Appalachian drug users: a cross-sectional comparison and retrospective survival analysis.
Young AM; Havens JR
Addiction; 2012 Mar; 107(3):587-96. PubMed ID: 21883604
[TBL] [Abstract][Full Text] [Related]
17. OxyContin abuse and overdose.
Aquina CT; Marques-Baptista A; Bridgeman P; Merlin MA
Postgrad Med; 2009 Mar; 121(2):163-7. PubMed ID: 19332974
[TBL] [Abstract][Full Text] [Related]
18. The effect of FDA approval of a generic competitor to OxyContin (oxycodone HCl controlled-release) tablets on the abuse of oxycodone.
Bailey JE; Barton PL; Lezotte D; Lowenstein SR; Dart RC
Drug Alcohol Depend; 2006 Sep; 84(2):182-7. PubMed ID: 16510252
[TBL] [Abstract][Full Text] [Related]
19. Exploring the potential link between Medicaid access restrictions, physician location, and health disparities.
Headen A; Masia N
Am J Manag Care; 2005 Jan; 11 Spec No():SP21-6. PubMed ID: 15700906
[TBL] [Abstract][Full Text] [Related]
20. Internet-based survey of nonmedical prescription opioid use in the United States.
Katz N; Fernandez K; Chang A; Benoit C; Butler SF
Clin J Pain; 2008; 24(6):528-35. PubMed ID: 18574362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
